Additionally, through expanding lung cancer patient sample size and conducting in vitro experiments, we confirmed that lung cancer immunotherapy resistance is closely associated with abnormal fat metabolism and verified its regulation on the infiltration of CD8+ T cell and the expression of checkpoint PD-L1 in lung cancer patients received immunotherapy. The gene discussed is CD8A; the disease is lung cancer.